

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.37504291 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.08587543 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.08587543 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.08587543 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.08587543 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.08587543 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.08587543 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.87408279 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.84498693 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49363982 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.39114209 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 4.15244273 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 4.14308529 |
| 14 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.08372719 |
| 15 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.00357572 |
| 16 | oxygen transport (GO:0015671) | 3.93060760 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.88514906 |
| 18 | response to peptidoglycan (GO:0032494) | 3.77269452 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.64555114 |
| 20 | gas transport (GO:0015669) | 3.60156195 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.59541673 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.58019890 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58019890 |
| 24 | respiratory burst (GO:0045730) | 3.58018981 |
| 25 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.57212882 |
| 26 | positive regulation of mast cell degranulation (GO:0043306) | 3.57212882 |
| 27 | regulation of platelet aggregation (GO:0090330) | 3.56319859 |
| 28 | regulation of cholesterol storage (GO:0010885) | 3.49704685 |
| 29 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.48592795 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48471546 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48471546 |
| 32 | detection of other organism (GO:0098543) | 3.41329313 |
| 33 | leukocyte degranulation (GO:0043299) | 3.40426506 |
| 34 | megakaryocyte development (GO:0035855) | 3.38065897 |
| 35 | response to host immune response (GO:0052572) | 3.37204619 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37204619 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 3.33285346 |
| 38 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.28612384 |
| 39 | myeloid cell development (GO:0061515) | 3.27819874 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27164960 |
| 41 | regulation of platelet activation (GO:0010543) | 3.26808000 |
| 42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.25648093 |
| 43 | erythrocyte development (GO:0048821) | 3.24905776 |
| 44 | pinocytosis (GO:0006907) | 3.19196558 |
| 45 | detection of bacterium (GO:0016045) | 3.12616142 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.10810979 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10650128 |
| 48 | granulocyte activation (GO:0036230) | 3.08178171 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.07885379 |
| 50 | definitive hemopoiesis (GO:0060216) | 3.07407388 |
| 51 | regulation of erythrocyte differentiation (GO:0045646) | 3.05369272 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05221246 |
| 53 | response to host defenses (GO:0052200) | 3.02147369 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02147369 |
| 55 | response to host (GO:0075136) | 3.02147369 |
| 56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01088741 |
| 57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.01079834 |
| 58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00393250 |
| 59 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.96873152 |
| 60 | natural killer cell mediated immunity (GO:0002228) | 2.96873152 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 2.94585787 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94111910 |
| 63 | neutrophil activation (GO:0042119) | 2.94005871 |
| 64 | erythrocyte maturation (GO:0043249) | 2.92007564 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 2.91208492 |
| 66 | regulation of mononuclear cell migration (GO:0071675) | 2.91079708 |
| 67 | apoptotic cell clearance (GO:0043277) | 2.89963824 |
| 68 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.88659600 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 2.87230021 |
| 70 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86371619 |
| 71 | pentose-phosphate shunt (GO:0006098) | 2.86341767 |
| 72 | angiotensin maturation (GO:0002003) | 2.84180564 |
| 73 | thrombin receptor signaling pathway (GO:0070493) | 2.83521723 |
| 74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.80580639 |
| 75 | regulation of regulated secretory pathway (GO:1903305) | 2.80068320 |
| 76 | B cell mediated immunity (GO:0019724) | 2.79558281 |
| 77 | lipoprotein transport (GO:0042953) | 2.78997521 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.78904682 |
| 79 | regulation of B cell differentiation (GO:0045577) | 2.78815074 |
| 80 | response to interferon-alpha (GO:0035455) | 2.78396764 |
| 81 | N-acetylneuraminate metabolic process (GO:0006054) | 2.77853067 |
| 82 | adenosine receptor signaling pathway (GO:0001973) | 2.77353933 |
| 83 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.74798273 |
| 84 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.73806662 |
| 85 | NADPH regeneration (GO:0006740) | 2.73259992 |
| 86 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.71858959 |
| 87 | germinal center formation (GO:0002467) | 2.71810846 |
| 88 | histamine secretion (GO:0001821) | 2.70168831 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69970694 |
| 90 | response to type I interferon (GO:0034340) | 2.69857479 |
| 91 | cellular extravasation (GO:0045123) | 2.69471968 |
| 92 | hemoglobin metabolic process (GO:0020027) | 2.68079294 |
| 93 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66475815 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.65699633 |
| 95 | type I interferon signaling pathway (GO:0060337) | 2.64561192 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.64561192 |
| 97 | granulocyte differentiation (GO:0030851) | 2.64102423 |
| 98 | regulation of granulocyte differentiation (GO:0030852) | 2.63703329 |
| 99 | negative regulation of lipid storage (GO:0010888) | 2.62891913 |
| 100 | reactive oxygen species biosynthetic process (GO:1903409) | 2.62891682 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.62590438 |
| 102 | cellular response to interferon-alpha (GO:0035457) | 2.61918681 |
| 103 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61457939 |
| 104 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.60637385 |
| 105 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.59631098 |
| 106 | positive regulation of B cell differentiation (GO:0045579) | 2.58996789 |
| 107 | glycosphingolipid catabolic process (GO:0046479) | 2.58642167 |
| 108 | negative regulation of interleukin-12 production (GO:0032695) | 2.57424164 |
| 109 | autophagic vacuole fusion (GO:0000046) | 2.55592559 |
| 110 | leukocyte cell-cell adhesion (GO:0007159) | 2.55093005 |
| 111 | macrophage activation (GO:0042116) | 2.54622212 |
| 112 | response to fungus (GO:0009620) | 2.54420939 |
| 113 | detection of molecule of bacterial origin (GO:0032490) | 2.53803502 |
| 114 | microglial cell activation (GO:0001774) | 2.53134457 |
| 115 | negative regulation of interleukin-17 production (GO:0032700) | 2.52904852 |
| 116 | platelet formation (GO:0030220) | 2.52721072 |
| 117 | myeloid leukocyte activation (GO:0002274) | 2.50528317 |
| 118 | plasma lipoprotein particle clearance (GO:0034381) | 2.48900053 |
| 119 | negative regulation of T cell mediated immunity (GO:0002710) | 2.47715869 |
| 120 | regulation of interferon-beta production (GO:0032648) | 2.47597201 |
| 121 | positive regulation of regulated secretory pathway (GO:1903307) | 2.47162658 |
| 122 | actin filament polymerization (GO:0030041) | 2.46882739 |
| 123 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.46513130 |
| 124 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.46413338 |
| 125 | positive thymic T cell selection (GO:0045059) | 2.46405396 |
| 126 | regulation of mast cell degranulation (GO:0043304) | 2.46265129 |
| 127 | neutrophil mediated immunity (GO:0002446) | 2.45365180 |
| 128 | leukocyte mediated cytotoxicity (GO:0001909) | 2.44761416 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44176735 |
| 130 | I-kappaB phosphorylation (GO:0007252) | 2.42885515 |
| 131 | actin nucleation (GO:0045010) | 2.40738494 |
| 132 | hepatocyte apoptotic process (GO:0097284) | 2.39371890 |
| 133 | regulation of macrophage chemotaxis (GO:0010758) | 2.38925466 |
| 134 | response to thyroid hormone (GO:0097066) | 2.38610911 |
| 135 | regulation of mast cell activation (GO:0033003) | 2.37601375 |
| 136 | cell adhesion mediated by integrin (GO:0033627) | 2.37512302 |
| 137 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34404398 |
| 138 | myeloid cell homeostasis (GO:0002262) | 2.34248974 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.31372786 |
| 140 | cellular response to virus (GO:0098586) | 2.31353087 |
| 141 | regulation of chemokine biosynthetic process (GO:0045073) | 2.31306382 |
| 142 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.30931147 |
| 143 | leukotriene metabolic process (GO:0006691) | 2.30711026 |
| 144 | negative regulation of mast cell activation (GO:0033004) | 2.30368103 |
| 145 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30024708 |
| 146 | protein-lipid complex assembly (GO:0065005) | 2.29429357 |
| 147 | regulation of leukocyte degranulation (GO:0043300) | 2.28919268 |
| 148 | positive regulation of mast cell activation (GO:0033005) | 2.28616264 |
| 149 | leukocyte aggregation (GO:0070486) | 2.28447069 |
| 150 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.28064710 |
| 151 | positive regulation of leukocyte degranulation (GO:0043302) | 2.27376814 |
| 152 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.25413385 |
| 153 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.24586879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.77032052 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.66835705 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.77525363 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.15722604 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13892983 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01593545 |
| 7 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93316902 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87575591 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83484124 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.72000039 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71404861 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70859116 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.59130845 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51943842 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.42194623 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34292446 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.28704114 |
| 18 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.25982586 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23906451 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20322500 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18867511 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13814889 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.11142968 |
| 24 | * NCOR1_26117541_ChIP-Seq_K562_Human | 2.10877984 |
| 25 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.04430783 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03590893 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02866162 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93509160 |
| 29 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.92314555 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92099775 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87431825 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81515739 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76228112 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74411548 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73214496 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71168244 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70462615 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70136516 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67881630 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65919730 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65632924 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63933652 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61616138 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60793096 |
| 45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.59325980 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55317892 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54790184 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.52895945 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51557958 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50327179 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49763307 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49629387 |
| 53 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41778600 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41518993 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41351987 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.39949859 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38368722 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36251736 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35731507 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34876592 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34011517 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33149387 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.32778877 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32365079 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31771701 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30634660 |
| 67 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30599079 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30197045 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29553029 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29289078 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28605475 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.28528847 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27898281 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24755257 |
| 75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23729197 |
| 76 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22404641 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22342715 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19506750 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18217060 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.16667889 |
| 81 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15929815 |
| 82 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15617574 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13345318 |
| 84 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12706689 |
| 85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11790239 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11214650 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10172622 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09969545 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09202492 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08577781 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08017755 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07772739 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07759046 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04702851 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04170363 |
| 96 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04045609 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03000768 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02529739 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02180916 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01804056 |
| 101 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01536023 |
| 102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00653411 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00338675 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99986039 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99862180 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99546977 |
| 107 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99128139 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99070455 |
| 109 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.98895011 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98679350 |
| 111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97627842 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96896856 |
| 113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96881301 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96866680 |
| 115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96070141 |
| 116 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94786297 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94709664 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92728435 |
| 119 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92303653 |
| 120 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91251054 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90626981 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90363062 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89578252 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89423008 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88972051 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88685526 |
| 127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88654151 |
| 128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88225427 |
| 129 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88148528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.37646204 |
| 2 | MP0003436_decreased_susceptibility_to | 3.02239349 |
| 3 | MP0005360_urolithiasis | 2.90039627 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.79261131 |
| 5 | MP0003303_peritoneal_inflammation | 2.67971993 |
| 6 | MP0003656_abnormal_erythrocyte_physiolo | 2.59686060 |
| 7 | MP0009840_abnormal_foam_cell | 2.59330610 |
| 8 | MP0003724_increased_susceptibility_to | 2.53237760 |
| 9 | MP0009785_altered_susceptibility_to | 2.47545696 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.44350350 |
| 11 | * MP0002419_abnormal_innate_immunity | 2.34815796 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.32084537 |
| 13 | MP0005451_abnormal_body_composition | 2.24617576 |
| 14 | MP0006082_CNS_inflammation | 2.16827411 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.12069961 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.11116199 |
| 17 | MP0005025_abnormal_response_to | 2.10956303 |
| 18 | MP0008004_abnormal_stomach_pH | 2.09616364 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.06168256 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.00771281 |
| 21 | MP0008260_abnormal_autophagy | 1.97611005 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.89496816 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.88412126 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.87904075 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.81485123 |
| 26 | MP0000685_abnormal_immune_system | 1.78138624 |
| 27 | MP0005387_immune_system_phenotype | 1.74751481 |
| 28 | MP0001790_abnormal_immune_system | 1.74751481 |
| 29 | MP0010307_abnormal_tumor_latency | 1.73647010 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.73530209 |
| 31 | MP0001800_abnormal_humoral_immune | 1.72694844 |
| 32 | MP0002132_abnormal_respiratory_system | 1.71587770 |
| 33 | MP0004947_skin_inflammation | 1.70237212 |
| 34 | MP0003186_abnormal_redox_activity | 1.66809631 |
| 35 | MP0002723_abnormal_immune_serum | 1.66775358 |
| 36 | MP0004147_increased_porphyrin_level | 1.65683928 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.64655021 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.63913153 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.63913153 |
| 40 | MP0000343_altered_response_to | 1.60971468 |
| 41 | * MP0001819_abnormal_immune_cell | 1.57050732 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.56039700 |
| 43 | * MP0002420_abnormal_adaptive_immunity | 1.55829719 |
| 44 | MP0009764_decreased_sensitivity_to | 1.51291385 |
| 45 | MP0002405_respiratory_system_inflammati | 1.49748257 |
| 46 | MP0003448_altered_tumor_morphology | 1.48493168 |
| 47 | MP0004510_myositis | 1.47878389 |
| 48 | MP0000858_altered_metastatic_potential | 1.47143943 |
| 49 | MP0008469_abnormal_protein_level | 1.46867275 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.44041993 |
| 51 | MP0001958_emphysema | 1.40238468 |
| 52 | MP0005671_abnormal_response_to | 1.39344879 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.37573537 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.35934321 |
| 55 | MP0009278_abnormal_bone_marrow | 1.35882182 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.32660698 |
| 57 | MP0000604_amyloidosis | 1.30989239 |
| 58 | MP0006054_spinal_hemorrhage | 1.29919215 |
| 59 | MP0003075_altered_response_to | 1.29903514 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.28616265 |
| 61 | MP0001853_heart_inflammation | 1.28421448 |
| 62 | MP0010329_abnormal_lipoprotein_level | 1.26819229 |
| 63 | MP0002006_tumorigenesis | 1.26252325 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.25957470 |
| 65 | MP0005023_abnormal_wound_healing | 1.23941780 |
| 66 | MP0002398_abnormal_bone_marrow | 1.23669215 |
| 67 | MP0000716_abnormal_immune_system | 1.21031826 |
| 68 | MP0000490_abnormal_crypts_of | 1.18107957 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.14739077 |
| 70 | MP0002722_abnormal_immune_system | 1.14000416 |
| 71 | MP0002429_abnormal_blood_cell | 1.12487516 |
| 72 | MP0002136_abnormal_kidney_physiology | 1.12387434 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.10993500 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.10942417 |
| 75 | MP0000609_abnormal_liver_physiology | 1.09249581 |
| 76 | MP0005164_abnormal_response_to | 1.08035497 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.06806199 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.03813735 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.02537923 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.02101061 |
| 81 | MP0009763_increased_sensitivity_to | 1.01178310 |
| 82 | MP0004019_abnormal_vitamin_homeostasis | 1.00941859 |
| 83 | MP0001666_abnormal_nutrient_absorption | 0.99154478 |
| 84 | MP0005166_decreased_susceptibility_to | 0.98359872 |
| 85 | MP0004883_abnormal_blood_vessel | 0.98314366 |
| 86 | MP0005275_abnormal_skin_tensile | 0.96968298 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.92583193 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.92202933 |
| 89 | MP0009115_abnormal_fat_cell | 0.90780818 |
| 90 | MP0001851_eye_inflammation | 0.90335020 |
| 91 | MP0002933_joint_inflammation | 0.90089038 |
| 92 | MP0005083_abnormal_biliary_tract | 0.88952722 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.88754522 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.87942943 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.87725085 |
| 96 | MP0005670_abnormal_white_adipose | 0.87608892 |
| 97 | MP0005332_abnormal_amino_acid | 0.87508026 |
| 98 | MP0005390_skeleton_phenotype | 0.86501328 |
| 99 | MP0003866_abnormal_defecation | 0.86489334 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.86124586 |
| 101 | MP0001663_abnormal_digestive_system | 0.85397704 |
| 102 | MP0005310_abnormal_salivary_gland | 0.84526679 |
| 103 | MP0000598_abnormal_liver_morphology | 0.84469777 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84199832 |
| 105 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83486360 |
| 106 | MP0001756_abnormal_urination | 0.82490011 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.82239881 |
| 108 | MP0003690_abnormal_glial_cell | 0.81737052 |
| 109 | MP0000249_abnormal_blood_vessel | 0.81537307 |
| 110 | MP0003828_pulmonary_edema | 0.81191027 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.79367657 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.78707415 |
| 113 | MP0005535_abnormal_body_temperature | 0.78704684 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.77924210 |
| 115 | MP0004130_abnormal_muscle_cell | 0.77588208 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 0.77325257 |
| 117 | MP0008874_decreased_physiological_sensi | 0.76615880 |
| 118 | MP0003252_abnormal_bile_duct | 0.75170512 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.69444184 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.68534491 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.68484706 |
| 122 | MP0003795_abnormal_bone_structure | 0.62620724 |
| 123 | MP0008995_early_reproductive_senescence | 0.59684658 |
| 124 | MP0005165_increased_susceptibility_to | 0.58778993 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54676150 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.53415318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 5.67266208 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.36434024 |
| 3 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.35284709 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.99152197 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.94603976 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.79468460 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.66768987 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.50171809 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.43588396 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.28748401 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.04689353 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.02166553 |
| 13 | Polycythemia (HP:0001901) | 3.81032780 |
| 14 | Axonal loss (HP:0003447) | 3.45383900 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.35363930 |
| 16 | Cholecystitis (HP:0001082) | 3.35363930 |
| 17 | Pustule (HP:0200039) | 3.31246399 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.29495690 |
| 19 | Menorrhagia (HP:0000132) | 3.26097285 |
| 20 | Gingivitis (HP:0000230) | 3.08219048 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06074026 |
| 22 | Hypochromic microcytic anemia (HP:0004840) | 2.94860952 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 2.88241434 |
| 24 | Optic neuritis (HP:0100653) | 2.88241434 |
| 25 | Nausea (HP:0002018) | 2.86420281 |
| 26 | Petechiae (HP:0000967) | 2.82875897 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.82026259 |
| 28 | Myositis (HP:0100614) | 2.81801908 |
| 29 | Disinhibition (HP:0000734) | 2.81192262 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 2.80655481 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78258784 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.78258784 |
| 33 | Recurrent skin infections (HP:0001581) | 2.76760937 |
| 34 | Cellulitis (HP:0100658) | 2.75643529 |
| 35 | Microcytic anemia (HP:0001935) | 2.73737303 |
| 36 | Myocardial infarction (HP:0001658) | 2.70370506 |
| 37 | Prostate neoplasm (HP:0100787) | 2.68785998 |
| 38 | Recurrent viral infections (HP:0004429) | 2.67548230 |
| 39 | Paralysis (HP:0003470) | 2.67511111 |
| 40 | Obstructive lung disease (HP:0006536) | 2.64734061 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.64734061 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62910418 |
| 43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62877263 |
| 44 | Osteolytic defects of the hand bones (HP:0009699) | 2.62877263 |
| 45 | Encephalitis (HP:0002383) | 2.61943495 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.61845531 |
| 47 | Cholelithiasis (HP:0001081) | 2.59527393 |
| 48 | Hypertensive crisis (HP:0100735) | 2.58877966 |
| 49 | Urticaria (HP:0001025) | 2.56451199 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.56449794 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56276208 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56276208 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56276208 |
| 54 | Meningitis (HP:0001287) | 2.53788003 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53034089 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53034089 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53034089 |
| 58 | Osteomyelitis (HP:0002754) | 2.51401261 |
| 59 | Poikilocytosis (HP:0004447) | 2.47384416 |
| 60 | Tetraparesis (HP:0002273) | 2.45698972 |
| 61 | Abnormal hemoglobin (HP:0011902) | 2.44331231 |
| 62 | Orchitis (HP:0100796) | 2.40966589 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.39691877 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.38912397 |
| 65 | Arterial thrombosis (HP:0004420) | 2.38299380 |
| 66 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.37374498 |
| 67 | Increased serum ferritin (HP:0003281) | 2.37015267 |
| 68 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.35896353 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.34062378 |
| 70 | Glomerulonephritis (HP:0000099) | 2.33011027 |
| 71 | Pathologic fracture (HP:0002756) | 2.32666003 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.31733554 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.31733554 |
| 74 | Cervical subluxation (HP:0003308) | 2.28556619 |
| 75 | Periodontitis (HP:0000704) | 2.28067492 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.27637785 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.25354979 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25059421 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.24526856 |
| 80 | Loss of speech (HP:0002371) | 2.22969814 |
| 81 | T lymphocytopenia (HP:0005403) | 2.22156465 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.21156217 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.18432301 |
| 84 | Hematochezia (HP:0002573) | 2.18147324 |
| 85 | Episodic fever (HP:0001954) | 2.17979572 |
| 86 | Increased IgM level (HP:0003496) | 2.17742308 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.16740384 |
| 88 | Peritonitis (HP:0002586) | 2.16724006 |
| 89 | Nephritis (HP:0000123) | 2.16422005 |
| 90 | Hypochromic anemia (HP:0001931) | 2.16143902 |
| 91 | Acanthocytosis (HP:0001927) | 2.15518353 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.14633480 |
| 93 | Xanthomatosis (HP:0000991) | 2.13931429 |
| 94 | Conjunctival telangiectasia (HP:0000524) | 2.13888545 |
| 95 | Purpura (HP:0000979) | 2.11893789 |
| 96 | Panhypogammaglobulinemia (HP:0003139) | 2.11542209 |
| 97 | Agnosia (HP:0010524) | 2.10300635 |
| 98 | Abnormality of T cell number (HP:0011839) | 2.10165273 |
| 99 | Abnormality of complement system (HP:0005339) | 2.08114293 |
| 100 | Reticulocytosis (HP:0001923) | 2.05367011 |
| 101 | Vasculitis (HP:0002633) | 2.04488326 |
| 102 | Hepatosplenomegaly (HP:0001433) | 2.04454914 |
| 103 | Chest pain (HP:0100749) | 2.04409003 |
| 104 | Leukocytosis (HP:0001974) | 2.03754791 |
| 105 | Premature rupture of membranes (HP:0001788) | 2.02962922 |
| 106 | Ileus (HP:0002595) | 2.02047801 |
| 107 | Stomatitis (HP:0010280) | 2.01438427 |
| 108 | Colitis (HP:0002583) | 2.00986902 |
| 109 | Hyperthyroidism (HP:0000836) | 2.00448096 |
| 110 | Thrombocytosis (HP:0001894) | 1.99672752 |
| 111 | Keratoconjunctivitis (HP:0001096) | 1.99500091 |
| 112 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98605462 |
| 113 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98605462 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.97286595 |
| 115 | Abnormal platelet function (HP:0011869) | 1.97286595 |
| 116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96931776 |
| 117 | Increased IgE level (HP:0003212) | 1.96542440 |
| 118 | Hypertriglyceridemia (HP:0002155) | 1.96510544 |
| 119 | Vertigo (HP:0002321) | 1.96068943 |
| 120 | Abnormality of reticulocytes (HP:0004312) | 1.95716276 |
| 121 | Anorexia (HP:0002039) | 1.95322014 |
| 122 | Abnormality of T cells (HP:0002843) | 1.95089775 |
| 123 | Eosinophilia (HP:0001880) | 1.94386233 |
| 124 | Complement deficiency (HP:0004431) | 1.94194788 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93989225 |
| 126 | Slow saccadic eye movements (HP:0000514) | 1.93353364 |
| 127 | Splenomegaly (HP:0001744) | 1.90251705 |
| 128 | Abnormal platelet volume (HP:0011876) | 1.89528933 |
| 129 | Abnormality of purine metabolism (HP:0004352) | 1.85974767 |
| 130 | Joint hemorrhage (HP:0005261) | 1.85534823 |
| 131 | Thoracic kyphosis (HP:0002942) | 1.81604856 |
| 132 | Epistaxis (HP:0000421) | 1.80737924 |
| 133 | Abnormality of the prostate (HP:0008775) | 1.80584401 |
| 134 | Thick nail (HP:0001805) | 1.80330374 |
| 135 | Nonimmune hydrops fetalis (HP:0001790) | 1.79982016 |
| 136 | Increased mean platelet volume (HP:0011877) | 1.79608859 |
| 137 | Nasal polyposis (HP:0100582) | 1.79313501 |
| 138 | Hemorrhage of the eye (HP:0011885) | 1.76834844 |
| 139 | Gingival bleeding (HP:0000225) | 1.76652294 |
| 140 | Bone pain (HP:0002653) | 1.76318759 |
| 141 | Chronic otitis media (HP:0000389) | 1.76212221 |
| 142 | Abnormality of the lumbar spine (HP:0100712) | 1.75482839 |
| 143 | Bone cyst (HP:0012062) | 1.75255392 |
| 144 | Mucosal telangiectasiae (HP:0100579) | 1.74920061 |
| 145 | Granulocytopenia (HP:0001913) | 1.73905186 |
| 146 | Combined immunodeficiency (HP:0005387) | 1.73003386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.55833636 |
| 2 | BLK | 3.37911654 |
| 3 | TBK1 | 2.65133358 |
| 4 | BMPR2 | 2.52791555 |
| 5 | MAP4K1 | 2.49852736 |
| 6 | MST1R | 2.41796283 |
| 7 | TYK2 | 2.38573746 |
| 8 | TRIB3 | 2.38138494 |
| 9 | RIPK4 | 2.33356290 |
| 10 | TAOK2 | 2.15772446 |
| 11 | PRPF4B | 2.10982767 |
| 12 | STK10 | 2.08248065 |
| 13 | NME2 | 2.06708595 |
| 14 | PIM2 | 2.02711234 |
| 15 | EIF2AK1 | 1.99869330 |
| 16 | KIT | 1.96648594 |
| 17 | MAP3K14 | 1.78823072 |
| 18 | NEK9 | 1.71205052 |
| 19 | ZAP70 | 1.70687549 |
| 20 | LRRK2 | 1.66803730 |
| 21 | MST4 | 1.65703451 |
| 22 | IRAK3 | 1.65472542 |
| 23 | IKBKE | 1.65016035 |
| 24 | TESK2 | 1.63124109 |
| 25 | IRAK4 | 1.62389927 |
| 26 | TAOK1 | 1.61768340 |
| 27 | GRK6 | 1.58008092 |
| 28 | SCYL2 | 1.56261532 |
| 29 | MAP3K1 | 1.55739250 |
| 30 | PKN2 | 1.52085654 |
| 31 | CAMK1D | 1.50278864 |
| 32 | PBK | 1.48552114 |
| 33 | TGFBR2 | 1.43452292 |
| 34 | IKBKB | 1.42066848 |
| 35 | JAK3 | 1.37541812 |
| 36 | FRK | 1.36400054 |
| 37 | CSF1R | 1.36304069 |
| 38 | JAK1 | 1.36135767 |
| 39 | CLK1 | 1.30144506 |
| 40 | RIPK1 | 1.28079657 |
| 41 | TRPM7 | 1.26471052 |
| 42 | BMX | 1.23738681 |
| 43 | RPS6KA4 | 1.22969085 |
| 44 | MAP2K3 | 1.22925678 |
| 45 | SYK | 1.22684403 |
| 46 | PIM1 | 1.22370657 |
| 47 | MAP3K10 | 1.22119471 |
| 48 | KDR | 1.20208551 |
| 49 | CSK | 1.19983287 |
| 50 | TTN | 1.15432089 |
| 51 | TNK2 | 1.15410310 |
| 52 | STK4 | 1.13673987 |
| 53 | MAP3K2 | 1.11146427 |
| 54 | HCK | 1.05556780 |
| 55 | RAF1 | 1.05499881 |
| 56 | ABL2 | 1.04685816 |
| 57 | EPHB1 | 1.04604545 |
| 58 | CDK6 | 0.99874905 |
| 59 | TESK1 | 0.99775477 |
| 60 | PTK6 | 0.96951349 |
| 61 | IRAK1 | 0.96412323 |
| 62 | LYN | 0.96199366 |
| 63 | PAK4 | 0.96103328 |
| 64 | TAOK3 | 0.94549613 |
| 65 | MAP3K8 | 0.94212231 |
| 66 | EEF2K | 0.92424035 |
| 67 | BTK | 0.92021993 |
| 68 | JAK2 | 0.89698945 |
| 69 | FES | 0.88798511 |
| 70 | PIK3CG | 0.88174736 |
| 71 | FLT3 | 0.88170121 |
| 72 | GRK7 | 0.87787847 |
| 73 | TXK | 0.87482989 |
| 74 | MAP3K11 | 0.86832408 |
| 75 | MAP3K3 | 0.85078510 |
| 76 | LCK | 0.84852668 |
| 77 | DAPK2 | 0.78310960 |
| 78 | STK3 | 0.76184425 |
| 79 | MATK | 0.75956621 |
| 80 | MET | 0.71161581 |
| 81 | IRAK2 | 0.70503938 |
| 82 | FGFR4 | 0.69985269 |
| 83 | FGR | 0.69219473 |
| 84 | PDK1 | 0.68547275 |
| 85 | KSR1 | 0.67022243 |
| 86 | PRKG2 | 0.66217481 |
| 87 | MOS | 0.65342181 |
| 88 | TEC | 0.64990158 |
| 89 | CAMKK2 | 0.64759413 |
| 90 | YES1 | 0.64257665 |
| 91 | MAP3K13 | 0.63091334 |
| 92 | MAP3K6 | 0.59661968 |
| 93 | PDPK1 | 0.59616500 |
| 94 | FGFR3 | 0.59090422 |
| 95 | HIPK2 | 0.56687348 |
| 96 | EGFR | 0.56477385 |
| 97 | GRK5 | 0.56382802 |
| 98 | MAPK12 | 0.55479980 |
| 99 | MAPK11 | 0.55427921 |
| 100 | PRKCD | 0.54823221 |
| 101 | MARK2 | 0.52913686 |
| 102 | SIK3 | 0.52564913 |
| 103 | ABL1 | 0.52040251 |
| 104 | NEK2 | 0.50395596 |
| 105 | RET | 0.49429190 |
| 106 | CHUK | 0.49252085 |
| 107 | PTK2B | 0.48074520 |
| 108 | CDK4 | 0.47912750 |
| 109 | MAP2K1 | 0.47862698 |
| 110 | MAPKAPK2 | 0.46188710 |
| 111 | CDK12 | 0.45123800 |
| 112 | MAPKAPK3 | 0.44875534 |
| 113 | MARK3 | 0.43763879 |
| 114 | ACVR1B | 0.42115445 |
| 115 | CAMK1G | 0.42094723 |
| 116 | ITK | 0.41943146 |
| 117 | PAK2 | 0.40581327 |
| 118 | SIK1 | 0.39110956 |
| 119 | CCNB1 | 0.38572721 |
| 120 | DYRK3 | 0.38233995 |
| 121 | MAP3K5 | 0.36762937 |
| 122 | CDC42BPA | 0.36143379 |
| 123 | PTK2 | 0.35667899 |
| 124 | DAPK3 | 0.35601212 |
| 125 | FYN | 0.35373249 |
| 126 | PLK2 | 0.34782644 |
| 127 | TGFBR1 | 0.33893150 |
| 128 | KSR2 | 0.33739351 |
| 129 | BRAF | 0.31283107 |
| 130 | PRKCQ | 0.30785355 |
| 131 | ALK | 0.30765055 |
| 132 | SGK3 | 0.30718916 |
| 133 | PAK1 | 0.30466469 |
| 134 | DYRK1B | 0.29107812 |
| 135 | MAP2K6 | 0.28699268 |
| 136 | WNK1 | 0.26616528 |
| 137 | PRKACG | 0.24602125 |
| 138 | MAPK3 | 0.22014438 |
| 139 | RPS6KC1 | 0.21391847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.20235607 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.82765996 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69676052 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.52022748 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.25651420 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04584961 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97895905 |
| 8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.95969329 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.95219738 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.93150406 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.90666260 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.90235601 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86896140 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83820967 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.81599852 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.75611839 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.69062337 |
| 18 | Mineral absorption_Homo sapiens_hsa04978 | 1.65762146 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56771191 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49255934 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48839766 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48665351 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48380610 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45564088 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.44071584 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42936773 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42496007 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.36840905 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34559973 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.33800722 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.31843727 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31778185 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29550841 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.27600713 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.26489135 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25975671 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.25581924 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25534513 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20324320 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20202816 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17385191 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16480882 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14065024 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13698008 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12573264 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12141783 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11749022 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.09471157 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.05547421 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04334021 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01966789 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99544012 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.97179735 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96551029 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96004486 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94807117 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.93505708 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91531183 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88085967 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84245150 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83688862 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82050834 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81496891 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81266936 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80068251 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79525103 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.78546922 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.76291059 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75109511 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73840217 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73820103 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73297791 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73061725 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71421794 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70558951 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69212968 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69083132 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68231763 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68219508 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65063145 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64984619 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.64815873 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64608032 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64126828 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.63446780 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63073405 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61902529 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61831993 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61382980 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61093111 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60706586 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60517964 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60419994 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58672103 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.58214206 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57418705 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57272782 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.57173455 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56946303 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55982628 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53471452 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52994253 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51484791 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.51446225 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51294803 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50316493 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50128862 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50000715 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.48183478 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48040100 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47676267 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44844693 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44322256 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.43615629 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43315666 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42399363 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41577067 |
| 118 | Proteasome_Homo sapiens_hsa03050 | 0.40665039 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35576381 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31358896 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31341964 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30742624 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30499945 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29566085 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29104743 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27529795 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27175826 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26211636 |

